A peptide derived from activity-dependent neuroprotective protein (ADNP) ameliorates injury response in closed head injury in mice

Journal of Pharmacology and Experimental Therapeutics

Volumn 296, Issue 1, 2001, Pages 57-63

  Beni Adani, Liana ^a   Gozes, Illana ^b   Cohen, Yoram ^b   Assaf, Yaniv ^b   Steingart, Ruth A ^b   Brenneman, Douglas E ^c   Eizenberg, Oded ^a   Trembolver, Victoria ^a   Shohami, Esther ^a,d  

^a HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

^c EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^d HEBREW UNIVERSITY OF JERUSALEM   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ASPARAGINYLALANYLPROLYLSERYLVALYLISOLEUCYLPROLYLGLUTAMINE; NEUROPEPTIDE; NEUROPROTECTIVE AGENT; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLOOD BRAIN BARRIER; BRAIN EDEMA; CONTROLLED STUDY; HEAD INJURY; MALE; MOUSE; NERVE CELL LESION; NERVE REGENERATION; NEUROPROTECTION; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; TISSUE LEVEL;

ANIMALS; BEHAVIOR, ANIMAL; BRAIN EDEMA; HEAD INJURIES, CLOSED; HOMEODOMAIN PROTEINS; MAGNETIC RESONANCE IMAGING; MALE; MICE; MICE, INBRED STRAINS; MUSCULOSKELETAL EQUILIBRIUM; NERVE TISSUE PROTEINS; NEUROPROTECTIVE AGENTS; PC12 CELLS; PEPTIDES; RATS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0035196833     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Diffusion- and T2-weighted MRI of closed head injury in rats: A time course study and correlation with histology
2. The complete sequence of a novel protein containing a femtomolar-activity-dependent neuroprotective peptide
3. Changes of biological reducing activity in rat brain following closed head injury: A cyclic voltammetry study in normal and heat-acclimated rats
4. Cerebroprotective effect of stable nitroxide radicals in closed head injury in the rat
5. Preventive actions of a synthetic antioxidant in a novel animal model of AIDS dementia
6. Vasoactive intestinal peptide and electrical activity influence neuronal survival
7. A femtomolar acting neuroprotective peptide
8. Activity-dependent neurotrophic factor: Structure activity relationships of femtomolar acting peptides
9. An experimental model of closed head injury in mice: Pathophysiology, histopathology and cognitive deficits
10. Motor and cognitive deficits in apolipoprotein E-deficient mice after closed head injury
11. Apoptosis, neurotrophic factors and neurodegeneration
12. The spectrum of traumatic axonal injury
13. Axonal injury: A universal consequence of fatal closed head injury?
14. VIP: Molecular biology and neurobiological function
15. Activity dependent neurotrophic factor (ADNF). An extracellular neuroprotective chaperonin?
16. Antiserum to activity dependent neurotrophic factor produces neuronal cell death in CNS cultures: Immunological and biological specificity
17. Pharmaceutical VIP: Prospects and problems
18. Activity-dependent neurotrophic factor: Intranasal administration of femtomolar-acting peptides improve performance in a water maze
19. Nerve growth factor inhibits apoptosis induced by tumor necrosis factor in PC12 cells
20. Vasoactive intestinal peptide and pituitary adenylyl cyclase-activating polypeptide inhibit tumor necrosis factor-alpha production in injured spinal cord and in activated microglia via a cAMP-dependent pathway
21. A preclinical development strategy designed to optimize the use of glial Cell line derived neurotrophic factor in the treatment of Parkinson's disease
22. Alterations in the fine structure of nucleoli in sympathetic neurons following NGF antiserum treatment
23. Calcium and neuronal injury in Alzheimer's disease. Contributions of beta-amyloid precursor protein mismetabolism, free radicals, and metabolic compromise
24. Novel pharmacologic strategies in the treatment of experimental traumatic brain injury
25. Axonal injury-a diagnostic tool in forensic neuropathology. A review
26. Vasoactive intestinal peptide (VIP) protects from dopamine toxicity: Relevance to Parkinson's disease
27. Effects of the NMDA antagonist CP-98,113 on regional cerebral edema and cardiovascular, cognitive, and neurobehavioral function following experimental brain injury in the rat
28. Head injury mechanisms and the concept of preventive management: A review and critical synthesis
29. The pathobiology of traumatically induced axonal injury in animals and humans: A review of current thoughts
30. Molecules that protect: The defense of neurons and other cells
31. Polypeptide with broad biological activity: Isolation from small intestine
32. Alzheimer's disease after remote head injury: An incidence study
33. Inhibition of tumor necrosis factor α activity in rat brain is associated with cerebroprotection after closed head injury
34. Dual role of tumor necrosis factor alpha in brain injury
35. Long-term effect of HU-211, a novel non-competitive NMDA antagonist, on motor and memory functions after closed head injury in the rat
36. Closed head injury triggers early production of TNFα and IL-6 by brain tissue
37. Antioxidants attenuate acute toxicity of tumor necrosis factor a induced by brain injury in rat
38. Diffuse neuronal perikaryon amyloid precursor protein immunoreactivity in a focal head impact model
39. Monitoring the impact of traumatic brain injury: A review and update
40. Involvement of cytokines in normal CNS development and neurological diseases: Recent progress and perspectives